equivalent to 2500 mg/m2 total daily dose) for 2 weeks followed by a 1-week rest period given as 3 week cycles

A clinical trial to study the bioequivlence study of Capeciatabine in Locally Advanced Breast Cancer or Metastatic Breast Cancer or Colorectal Cancer patients under fed condition

To assess the safety and tolerability of a single oral dose of the Capecitabine test and reference formulations.